Investigational Combined Measles, Mumps, Rubella, Varicella Vaccine Study

Now Enrolling Children Ages 4 to 6 Years

Now Enrolling

About this research study

Measles, mumps, rubella, and varicella are viral infections which can lead to serious complications, disability, and death of infected individuals. In the U.S., Scientists are researching an investigational vaccine to potentially prevent these infections in children.

Velocity is conducting a clinical research study for an investigational combined measles, mumps, rubella, varicella vaccine for children.

Eligible participants...

  • Must be age 4 to 6 years
  • Must have received a first dose of varicella-containing vaccine and measles-, mumps-, rubella containing vaccine in the second year of life
  • Must NOT have a history of measles, mumps, rubella, or varicella disease
  • Must NOT have a hypersensitivity to latex
  • Will receive compensation for study-related time

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Lafayette, Louisiana • Velocity Clinical Research

401 Youngsville Hwy, Suite 100, Lafayette, LA 70508
Phone: (337) 451-0663
Row concave Shape Decorative svg added to top

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy